Flow cytometry susceptibility testing for the antifungal caspofungin

被引:15
|
作者
Mitchell, M [1 ]
Hudspeth, M
Wright, A
机构
[1] Community Med Ctr Fresno, Dept Microbiol, Fresno, CA 93701 USA
[2] Calif State Univ Fresno, Dept Biol, Fresno, CA 93720 USA
关键词
D O I
10.1128/JCM.43.6.2586-2589.2005
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
Rapid antifungal susceptibility testing for the antifungal agent caspofungin can be performed using flow cytometry (FC). An FC procedure using acridine orange provided minimum inhibitory concentration (MIC) results within 7 to 9 h which were compared with results obtained using the NCCLS M27-A2 protocol. To evaluate the consistency of this method, susceptibility testing using caspofungin was performed using 73 isolates of eight different species of Candida from various clinical samples in Central California. Macrotiter or microdilution tests were performed according to the NCCLS M27-A2 protocol, and the MICs were compared to those provided by our How cytometry method. All isolates tested had results within the sensitive interpretive category, and 90% of the results compared within I dilution, showing excellent agreement between the methods. The MIC at which 50% of the isolates tested were inhibited (MIC50) and the MIC90 of caspofungin for all eight Candida species were within 1 dilution. This flow cytometer 7-h protocol for testing the antifungal susceptibility of Candida species to caspofungin provided results equivalent to those obtained with the M27-A2 protocol.
引用
收藏
页码:2586 / 2589
页数:4
相关论文
共 50 条
  • [31] Comparison of the Antifungal Susceptibility Testing Subcommittee of the European Committee on Antibiotic Susceptibility Testing proposed standard and the E-test with the NCCLS broth microdilution method for voriconazole and caspofungin susceptibility testing of yeast species
    Chryssanthou, E
    Cuenca-Estrella, M
    JOURNAL OF CLINICAL MICROBIOLOGY, 2002, 40 (10) : 3841 - 3844
  • [32] Personalized antifungal susceptibility testing
    Shah, PM
    JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 1999, 44 (02) : 291 - 291
  • [33] Issues in antifungal susceptibility testing
    Johnson, Elizabeth M.
    JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2007, 61 : I13 - I18
  • [34] STANDARDIZATION OF ANTIFUNGAL SUSCEPTIBILITY TESTING
    GALGIANI, JN
    RINALDI, MG
    POLAK, AM
    PFALLER, MA
    JOURNAL OF MEDICAL AND VETERINARY MYCOLOGY, 1992, 30 : 213 - 224
  • [35] Antifungal susceptibility testing methods
    Pfaller, MA
    CURRENT DRUG TARGETS, 2005, 6 (08) : 929 - 943
  • [36] ANTIFUNGAL DRUG SUSCEPTIBILITY TESTING
    VANCUTSEM, J
    KURATA, H
    MATSUOKA, H
    MIKAMI, Y
    PFALLER, MA
    SCALARONE, GM
    RINALDI, MG
    JOURNAL OF MEDICAL AND VETERINARY MYCOLOGY, 1994, 32 : 267 - 276
  • [37] An update on antifungal susceptibility testing
    Tapia P, Cecilia F.
    REVISTA CHILENA DE INFECTOLOGIA, 2009, 26 (02): : 144 - 150
  • [38] In vitro antifungal susceptibility testing
    Hoffman, HL
    Pfaller, MA
    PHARMACOTHERAPY, 2001, 21 (08): : 111S - 123S
  • [39] Personalized antifungal susceptibility testing
    Conti, S
    Fanti, F
    Bertolotti, D
    Dieci, E
    Arseni, S
    Salati, A
    Polonelli, L
    JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 1999, 43 (03) : 333 - 338
  • [40] Antifungal drug susceptibility testing
    Rogers, TRF
    Barnes, RA
    Denning, DW
    Evans, EGV
    Hay, RJ
    Prentice, AG
    Speller, DCE
    Warnock, DW
    Warren, RE
    JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 1995, 36 (06) : 899 - 909